Can open-source R&D reinvigorate drug research?

Nat Rev Drug Discov. 2006 Sep;5(9):723-9. doi: 10.1038/nrd2131. Epub 2006 Aug 18.

Abstract

The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?

Publication types

  • Review

MeSH terms

  • Clinical Trials as Topic / methods
  • Databases, Factual*
  • Drug Approval / methods
  • Drug Design
  • Humans
  • Organizational Innovation
  • Research / organization & administration
  • Research / trends
  • Research Design*
  • Software*
  • Technology, Pharmaceutical / methods
  • Technology, Pharmaceutical / trends